Fundraising Fox

Chordia Therapeutics

5 known investors

Cancer therapeutics development (RNA regulation abnormalities).

Investors · 5

Kyoto University Innovation CapitalKyoto
Nippon Venture CapitalTokyo · $1.5M – $269M
Shinsei Capital PartnersTokyo
SMBC Venture CapitalTokyo · $2.3M – $269Mvia Hiroya Ota · inferred
UTokyo Innovation Platform Co. Ltd.Tokyo

In the news

Chordia Therapeutics Stock Price | Stock Quote, News, and History | Markets Insidermarkets.businessinsider.com · Aug 2026Chordia Therapeutics Inc. announced that it expects to receive ¥10.3888 million in funding from SBI Securities Co., Ltd. | MarketScreenermarketscreener.com · Sep 2025Chordia Therapeutics Enhances Transparency with Earnings Transcript | Nasdaqnasdaq.com · Oct 2024Ten pioneering biotech companies spearheading Japan's industrylabiotech.eu · Feb 2024Takeda spins off cancer assets to incubated startup | Fierce Biotechfiercebiotech.com · Nov 2017

Frequently asked questions

What does Chordia Therapeutics do?
Cancer therapeutics development (RNA regulation abnormalities).
Who are Chordia Therapeutics's investors?
Chordia Therapeutics's investors include Kyoto University Innovation Capital, Nippon Venture Capital, Shinsei Capital Partners, SMBC Venture Capital, UTokyo Innovation Platform Co. Ltd..